# Genentech, Inc.

Organization · id `cardio:org-genentech-inc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Genentech%2C+Inc.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Genentech, Inc.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER) (`cardio:ct-nct01258907`)
- Sponsors: A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease (`cardio:ct-nct01609140`)
- Sponsors: Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III (`cardio:ct-nct01827046`)
- Sponsors: A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke (`cardio:ct-nct02072226`)
- Sponsors: Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease (`cardio:ct-nct04258397`)
- Sponsors: A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events (`cardio:ct-nct07448038`)

## Provenance

Content hash: c120629ee2d4e3fc6de4d7e967cba2bfb9c8aa76cc5378267f7cf2bb95938a48
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
